Welcome to LookChem.com Sign In|Join Free

CAS

  • or

24824-86-0

Post Buying Request

24824-86-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

24824-86-0 Usage

Physical state

Colorless liquid

Odor

Sweet, floral

Uses

a. Flavoring agent in food and beverage industry
b. Production of pharmaceuticals
c. Production of fragrances
d. Synthesis of other organic compounds

Safety precautions

a. Harmful if ingested
b. Harmful if inhaled
c. Harmful if absorbed through the skin

Environmental hazard

Yes, should be disposed of properly to minimize environmental impact

Check Digit Verification of cas no

The CAS Registry Mumber 24824-86-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,8,2 and 4 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 24824-86:
(7*2)+(6*4)+(5*8)+(4*2)+(3*4)+(2*8)+(1*6)=120
120 % 10 = 0
So 24824-86-0 is a valid CAS Registry Number.

24824-86-0Relevant articles and documents

Nickel-catalyzed deallylation of aryl allyl ethers with hydrosilanes

Ding, Guangni,Fan, Sijie,Wang, Jingyang,Wang, Yu,Wu, Xiaoyu,Xie, Xiaomin,Yang, Liqun,Zhang, Zhaoguo

supporting information, (2021/09/28)

An efficient and mild catalytic deallylation method of aryl allyl ethers is developed, with commercially available Ni(COD)2 as catalyst precursor, simple substituted bipyridine as ligand and air-stable hydrosilanes. The process is compatible with a variety of functional groups and the desired phenol products can be obtained with excellent yields and selectivity. Besides, by detection or isolation of key intermediates, mechanism studies confirm that the deallylation undergoes η3-allylnickel intermediate pathway.

Structure-guided design, synthesis and evaluation of oxazolidinone-based inhibitors of norovirus 3CL protease

Damalanka, Vishnu C.,Kim, Yunjeong,Galasiti Kankanamalage, Anushka C.,Rathnayake, Athri D.,Mehzabeen, Nurjahan,Battaile, Kevin P.,Lovell, Scott,Nguyen, Harry Nhat,Lushington, Gerald H.,Chang, Kyeong-Ok,Groutas, William C.

, p. 881 - 890 (2017/12/26)

Acute nonbacterial gastroenteritis caused by noroviruses constitutes a global public health concern and a significant economic burden. There are currently no small molecule therapeutics or vaccines for the treatment of norovirus infections. A structure-gu

INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)

-

Page/Page column 143, (2010/06/15)

The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein ("FABP") inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the present invention is shown below: (I)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 24824-86-0